These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30947871)

  • 41. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatobiliary disorders and complications of inflammatory bowel disease.
    Venkatesh PG; Navaneethan U; Shen B
    J Dig Dis; 2011 Aug; 12(4):245-56. PubMed ID: 21791019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
    Silva J; Brito BS; Silva INN; Nóbrega VG; da Silva MCSM; Gomes HDN; Fortes FM; Pimentel AM; Mota J; Almeida N; Surlo VC; Lyra A; Rocha R; Santana GO
    Biomed Res Int; 2019; 2019():7604939. PubMed ID: 30834274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
    Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A
    J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary sclerosing cholangitis.
    Milkiewicz P; Wunsch E
    Recent Results Cancer Res; 2011; 185():117-33. PubMed ID: 21822823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pyostomatitis vegetans and primary sclerosing cholangitis: markers of inflammatory bowel disease.
    Philpot HC; Elewski BE; Banwell JG; Gramlich T
    Gastroenterology; 1992 Aug; 103(2):668-74. PubMed ID: 1634082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
    Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
    J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in primary sclerosing cholangitis.
    Horsley-Silva JL; Carey EJ; Lindor KD
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):68-77. PubMed ID: 28404115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An update on primary sclerosing cholangitis.
    Maggs JR; Chapman RW
    Curr Opin Gastroenterol; 2008 May; 24(3):377-83. PubMed ID: 18408468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease.
    Bramuzzo M; Martelossi S; Torre G; Cardile S; Arrigo S; Vignola S; Ferrari F; Zuin G; Illiceto MT; Gasparetto M; Pellegrino S; Romano C; Maggiore G; Montico M; Aloi M;
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):259-64. PubMed ID: 26756875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.
    Liu K; Strasser SI; Koorey DJ; Leong RW; Solomon M; McCaughan GW
    Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):949-960. PubMed ID: 28627935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome complicated by inflammatory bowel disease.
    Lamia S; Sana K; Rachid J; Hajer A; Leila M; Nabil T; Mongia H
    Tunis Med; 2012 Dec; 90(12):899-900. PubMed ID: 23247795
    [No Abstract]   [Full Text] [Related]  

  • 55. Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches.
    Sarkar S; Bowlus CL
    Clin Liver Dis; 2016 Feb; 20(1):67-77. PubMed ID: 26593291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic and biliary tract disorders in inflammatory bowel disease.
    Huang C; Lichtenstein DR
    Gastrointest Endosc Clin N Am; 2002 Jul; 12(3):535-59. PubMed ID: 12486943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatobiliary complications of idiopathic intestinal inflammations].
    Lukás M
    Cas Lek Cesk; 1997 Feb; 136(4):106-10. PubMed ID: 9221179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms.
    Marciano F; Savoia M; Vajro P
    Dig Liver Dis; 2016 Feb; 48(2):112-9. PubMed ID: 26711682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Primary sclerosing cholangitis : Current diagnostics and treatment].
    Liwinski T; Schramm C
    Internist (Berl); 2018 Jun; 59(6):551-559. PubMed ID: 29700559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.
    Heikius B; Niemelä S; Lehtola J; Karttunen T; Lähde S
    Scand J Gastroenterol; 1997 Feb; 32(2):153-61. PubMed ID: 9051876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.